ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Chicago, IL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Human Influenza
Coronavirus Infections
Communicable Diseases
Post-Acute COVID-19 Syndrome
Pneumonia
Respiratory Distress Syndrome

COVID-19 trials near Chicago, IL, USA:

Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial

Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of STRI Formula in Non-Hospitalized Participants with COVID...

Enrolling
Covid19
Drug: STRI Formula
Drug: Placebo

Phase 2

Eyecheck

Oak Forest, Illinois, United States and 12 other locations

of the study is to assess the safety and immunogenicity of IIV-HD (high-dose inactivated influenza vaccine) + rC19 (adjuvanted recombinant COVID...

Active, not recruiting
COVID-19 Immunization
Influenza Immunization
Biological: IIV-HD + rC19 (dose 4)
Biological: IIV-HD + rC19 (dose 3)

Phase 1, Phase 2

Sanofi
Sanofi

Chicago, Illinois, United States and 11 other locations

vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...

Enrolling
COVID-19
SARS-CoV2
Biological: VXA-CoV2-3.1
Biological: VXA-CoV2-3.3

Phase 2

Vaxart

Chicago, Illinois, United States and 144 other locations

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Chicago, Illinois, United States and 66 other locations

The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...

Enrolling
COVID-19 SARS-CoV-2 Infection
Drug: placebo
Drug: ibuzatrelvir

Phase 3

Pfizer
Pfizer

Oak Brook, Illinois, United States and 121 other locations

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 3

Pfizer
Pfizer

Chicago, Illinois, United States and 74 other locations

The purpose of this study is to evaluate the immunogenicity, reactogenicity, and safety, of mRNA-1083 multicomponent influenza and COVID-19...

Enrolling
Influenza
SARS-CoV-2
Biological: COVID-19 Vaccine
Biological: Investigational COVID-19 Vaccine Lot B

Phase 2

Moderna
Moderna

Melrose Park, Illinois, United States and 16 other locations

the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...

Enrolling
Myocarditis
Diagnostic Test: Cardiac Imaging

Phase 4

Pfizer
Pfizer

Chicago, Illinois, United States and 31 other locations

side effects. However, it was an expensive treatment and was eventually replaced with less expensive treatment options like penicillin.The COVID...

Active, not recruiting
Covid-19
Sars-CoV2
Radiation: Low dose radiation 35 cGy
Radiation: High dose radiation 100 cGy

Phase 2

The Ohio State University
The Ohio State University

Maywood, Illinois, United States and 6 other locations

This study will evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...

Enrolling
SARS-CoV-2
Biological: mRNA-1273.815
Biological: mRNA-1273.214

Phase 3

Moderna
Moderna

Chicago, Illinois, United States and 73 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems